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Effects of Artcure Diffusional Patch application on pain and functional status in lumbar
disc herniation patients: a prospective randomized controlled study
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Background/aim: The aim of this study was to assess the efficacy of the Artcure Diffusional Patch, which contains a mixture of 6 herbal
oils (oleum thymi, oleum limonis, oleum nigra, oleum rosmarini, oleum chamomilla, oleum lauriexpressum) and has a hypoosmolar
lipid structure, in the conservative treatment of lumbar disc herniation patients and to show the advantages and/or possibility of using
this as an alternative method to surgery.
Materials and methods: Of the 120 patients enrolled, 79 clinically diagnosed patients were included in the study. Clinical evaluations
were performed on patients who had findings of protrusion or extrusion in their magnetic resonance results. The treatment group was
treated with the Artcure Diffusional Patch while the control group received a placebo transdermal diffusional patch. The functional state
of patients was measured using the Oswestry Disability Index and pain intensity was measured with a visual analog scale as primary
outcomes. Secondary outcomes of the study were Lasegue’s sign, the femoral stretching test, and paravertebral muscle spasm.
Results: The treatment group showed a dramatic recovery in the first month following the application in regards to Oswestry Disability
Index scores and visual analog scale values. The patients treated with the Artcure Diffusional Patch showed a statistically significant
difference in recovery as compared to the control group.
Conclusion: These findings suggest that the Artcure Diffusional Patch may be an alternative for the conservative treatment of lumbar
disc herniation with radiculopathy.
Key words: Lumbar disc herniation, Artcure Diffusional Patch, Oswestry Disability Index

1. Introduction
Among Western societies 84% of adults suffer from low back
pain at some time in their lives (1). Low back pain is the
most frequent reason for disability in the population below
the age of 45 (2). The treatment costs for low back pain are
a significant part of medical costs and at about 34 billion
dollars; by adding the economic loss due to workforce
loss, this number increases to 100 billion dollars in the
United States (3,4). Lumbar disc herniation with associated
radiculopathy (LDHR) ranks first among the diseases
that cause low back pain. For this reason, an inexpensive,
noninvasive, and efficient treatment method is required in
order to reduce and delay surgical interventions of LDHR
patients and minimize the workforce loss during the period
until surgical intervention.
Lumbar disc herniation is the displacement of the
nucleus pulposus by the breaching of the annulus fibrosus
(5). With increasing age disc degeneration and disc height
* Correspondence: atifaksekili@yahoo.com

874

loss occur by the loss of proteoglycan and the effects of
proinflammatory cytokines (6). As a result of these, clinical
signs such as pressure on nerve roots and the spine occur.
The purpose of treatment is reducing the pain and increasing
the functional activity by removing the pressure on the
nerve roots by either surgical or conservative methods.
The decision between surgical and nonsurgical
management of LDHR can be challenging for both the
patient and the treating physician. Generally surgical
intervention is suggested to patients with acute and
progressive neurological deficit and those who are
nonresponsive to conservative treatments (7). In light of
the costs of surgical treatments and the scale of possible
complications, noninvasive treatment becomes the best
option. Since the intervertebral discs are the largest
avascular structures of the body, nourishment is supplied by
diffusion. Because of this avascularity, there is no possibility
for spontaneous recovery (8).
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The Artcure Diffusional Patch (ADP) contains a
mixture of 6 herbal oils (oleum thymi, oleum limonis,
oleum nigra, oleum rosmarini, oleum chamomilla, oleum
lauriexpressum) and has a hypoosmolar lipid structure.
These hypoosmolar fatty acids have been used in therapy
before, but this is the first time that they are being used in
combination for the treatment of lumbar disc herniation.
These fatty acids are not dosed sufficiently for therapeutic
use. These oil ingredients of ADP increase the membrane
permeability of the herniated nucleus pulposus, decrease
the intraosmotic pressure, and cause water loss by
diffusion. By these antiinflammatory and antiedema
effects, the mass decreases. By using dextrin palmitate, the
hypoosmolar fatty acids were formulated as a gel. As the
dissolvent of dextrin palmitate, liquid paraffin was used.
The purpose of this study was to assess the efficacy of the
ADP in the conservative treatment of patients with lumbar
disc herniation and to show the advantages of/possibility
of using it as an alternative method of nonsurgical
intervention to surgery.
2. Materials and methods
The study was conducted prospectively in 2014 and
2015 as a randomized placebo controlled trial with
patients admitted to the orthopedics, traumatology, and
physiotherapy clinics at the Yıldırım Beyazıt University
Atatürk Training and Research Hospital, Ankara,
Turkey. The study was performed under the terms of the
Declaration of Helsinki and the protocol was approved by
the ethics committee of the institution (approval date and
number: 03.09.2014–26379996/151).
Patients were eligible if they were in the age range of
20–60 years, had been referred for pain in one or two lower
extremities that caused functional disability, had findings in
magnetic resonance results such as protrusion or extrusion,
had radiological findings that conformed with discogenic
sciatica that followed a dermatomal distribution, and had
low back pain refractory to physiotherapy and NSAIDs.
Sciatica was defined as the presence of constant or
intermittent pain in one or both legs, radiating below the
knee. Signs of nerve root irritation (a positive straight-leg
test, defined as reproduction of radicular pain by elevation
of the leg ) or nerve root compression (motor, sensory, or
reflex deficits), or both, had to be present with computed
tomographic evidence of a herniated nucleus pulposus at a
level corresponding to the symptoms and clinical findings.
Patients were excluded if they had lumbar surgery,
spinal stenosis or deformity (scoliosis, spondylolysis,
vertebral fracture sequelae), loss of motor activity at ≥3/5
in any lower extremity muscle section, uncontrolled acute
or chronic systemic diseases, or atopic skin.
Outcomes were assessed using a visual analog scale
(VAS) for the degree of pain, while the Oswestry Disability

Index (ODI) was used in order to evaluate the functional
state, patient satisfaction, return to military duty, and need
for additional surgery. Lasegue’s sign and femoral stretch
test results were also recorded. Magnetic resonance imaging
was evaluated by two experienced neuroradiologists
and a radiological diagnosis was made. Each patient was
examined by the same physician throughout the trial. The
physicians and nurses involved in these assessments were
unaware of the treatment received.
Secondary outcomes were measured by physical
examination (disability of movement, test of Lasegue’s
sign, femoral stretching test, paravertebral muscle
spasm). The VAS, ODI, and physical examinations were
administered before the application of the patches, on the
third day after application, and the first month thereafter.
If a patient’s functional state recovery, pain reduction, and
negative score in the Lasegue test were more than 50%, the
recovery was accepted as significant (9,10).
Demographic information, medical history, and
physical examination findings of patients were recorded
and served as the baseline.
Randomization took place after we had obtained
written informed consent from the study participants and
gathered baseline information. The assignment scheme
was generated from the patient’s hospital files. The patients
were divided into two groups by using the last numbers
of the patient’s hospital files: odd numbers were included
in the ADP group (treatment group) and patients with
even numbers were included in the control transdermal
diffusional patch (TDP) group (control group).
The patches used as TDPs and applied to the patients in
the control group were similar to the ADP in appearance
and size. The same inactive ingredients in the gel structure
of the ADP (dextrin palmitate derivative and liquid
paraffin) were used in TDPs but as for liquid components
to change the osmotic gradient, glycerin was used instead
and evenly (11).
Ninety-seven patients (48 males, 49 females) with a
mean age of 43.1 years (range: 18–60 years) were admitted
to the study. The average duration of complaints of low
back pain was 2 years (range: 0.5–20 years) and 50.6% of
patients had right while 49.4% of patients had left radicular
pain. There was no statistically significant difference
between the two groups regarding the demographic data
of the level of hernia and anatomical type of herniation.
The patients in the ADP group mostly had multiple levels
of hernia, while the patients in the TDP group mostly
had a single level of hernia (P = 0.001). According to the
anatomical type of herniation, the patients in the ADP
group mostly had bulging-type hernias, while the patients
in the TDP group had more protruded discs (P < 0.001)
(Table 1).
The superior border of the iliac crest was palpated
while the patients were lying in a prone position and the
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Table 1. Demographical data of groups. Independent t-test (bootstrap) - Mann–Whitney U test (Monte Carlo) Fisher exact test (exact) - Pearson chi-square test (Monte Carlo). Average data ± standard deviation; median (range);
n (%).

Age
Sex

Marital status

Level of herniation

n = 46 (47.4)

n = 51 (52.6)
43.8 ± 10.77

0.458

24 (52.2)

25 (49.0)

0.840

Male

22 (47.8)

26 (51.0)

26.1 ± 4.26

27.8 ± 4.09

0.053

No

29 (63.0)

33 (64.7)

1

Yes

17 (37.0)

18 (35.3)

Single

10 (21.7)

6 (11.8)

Married

36 (78.3)

45 (88.2)

2 (0.5–12)

2 (0.5–20)

0.452

Right

22 (47.8)

26 (51.0)

0.840

Left

24 (52.2)

25 (49.0)

Multiple

8

26

Single

38

25

Protruded

34

26

Extruded

12

25

Central

21

26

Posterolateral

25

25

Type of herniation (anatomically)

Type of herniation (location)

0.273

0.001
<0.001

L4–5 level was determined. The level of disc pathology was
identified by drawing a line with a dermal pen. The center
of the patch was placed on the marked area (Figure 1). The
patients were hospitalized for 24 h and held in a supine
position. They were allowed to stand up for a maximum of 3
times each hour during 24 h. All of the patients showed full
compliance with the study protocols and exercise program.
None of the patients needed bracing applications.
The patients rated the perceived degree of overall
improvement or deterioration on a descriptive seven-item
scale that ranged from very marked improvement to very
marked deterioration. The intensity of leg pain in the week
preceding the visit was assessed on a VAS ranging from 0 (no
pain) to 100 (worst pain possible). The patients completed
two components of the McGill Pain Questionnaire. The
first component measures the present intensity of pain
on the basis of the response to one question, recorded as
a number from 0 (no pain) to 5 (excruciating pain). The
second component is a pain-rating index involving 77
pain descriptors (e.g., lancinating, cramping, and burning)
grouped into 20 categories. The descriptors in each
category are ranked numerically according to the severity
of pain. Patients can choose no more than one descriptor
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P-value

42.3 ± 9.59

Duration of low back pain (years)
Radicular pain

Experiment

Female

BMI
Smoking

Control

0.053

per category. The score for the pain-rating index, which
corresponds to the sum of the numerical values of the
descriptors chosen by the patient, ranges from 0 (no pain)
to 77 (the most severe pain in every category).
Functional disability was assessed with the Oswestry
Low Back Pain Disability Questionnaire and the Sickness
Impact Profile, both slightly modified by adding “and/or
leg” to all statements that contained the word “back”. The
Oswestry Low Back Pain Disability Questionnaire has 10
sections, on walking, sleeping, and social activities . The
overall score ranges from 0 to 100, with a score of 20 or
less indicating minimal disability for which no treatment
is usually indicated and higher scores indicating greater
disability. The Sickness Impact Profile measures perceived
health status and changes in functional status due to sickness.
It consists of 136 questions grouped into 12 categories (e.g.,
physical dimensions and psychosocial dimensions). Both
instruments have been shown to be reliable and sensitive
to changes in patients with low back pain. The patients also
reported the number of days in the previous 2 weeks when
they had limited their activities because of back or leg pain.
During data analysis, SPSS 22.0 (IBM Corp., Armonk,
NY, USA) and PAST3 (Øyvind Hammer, Natural History
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Figure 1. ADP application.

Museum, University of Oslo, Oslo, Norway) were used,
and for power analysis the G Power program was used.
The Shapiro–Wilk test was used for the compliance of
normal distribution of univariate data and the Mardia
(Doornik–Hansen omnibus) test was used for the
compliance of normal distribution of multivariate data.
The Levene test was used for homogeneity of variance.
The independent-samples t-test was used with bootstrap
results in order to compare two independent groups
and the Mann–Whitney U test was used for simulation
techniques. The general linear model-repeated ANOVA
test was used with Cochran’s Q test in order to measure
measurements of dependent variables repeated more
than two times. Nonparametric (Miller) post hoc tests
and least significant difference (LSD) tests were used for
post hoc analysis. For comparison of categorical data
Pearson chi-square and Fisher exact tests were used and

tested by Monte Carlo simulation technique. For the
determination of the most important risk factor among
the significant categorical risk factors the odds ratio was
used. Quantitative data were expressed as mean ± standard
deviation and median (maximum–minimum) values
and were tabulated. Categorical data were expressed as n
(number) and percentage (%). The 95% confidence levels
were set and P values were accepted to be significant at P
< 0.05.
Fifteen percent of the total patients admitted to these
clinics complained of low back pain. Therefore, two
groups were formed presuming this rate as 20% in order
to increase the power of our sample size.
ADP, which was applied to Group 1, contains a
mixture of 6 herbal oils (oleum thymi, oleum limonis,
oleum nigra, oleum rosmarini, oleum chamomilla, oleum
lauriexpressum) and has a hypoosmolar lipid structure.
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3. Results
A total of 120 patients were enrolled (Figure 2). Three
patients had had lumbar surgery before and 2 patients had
scoliosis deformation; therefore, they were excluded from
the study. Eighteen patients declined to participate in
the study for various reasons. The remaining 97 patients
were randomly divided into two groups. During the
study, 11 of 51 patients who received the ADP and 7 of
46 patients who received the TDP were excluded due to
noncompliance. Consequently, 40 patients who received
the ADP and 39 patients who received the TDP were
evaluated. The baseline characteristics were similar in the
two groups (Table 1).
After the patients were evaluated clinically and
radiologically and all of the data were gathered at the final
visit in March 2016, the study was terminated.
When comparing the ODI scores, VAS values, and
physical examination findings of the treatment and control
groups, there was statistically significant difference only
in paravertebral muscle spasms (P = 0.035). There were
no statistically significant differences between the other
values (Table 2).
In the treatment group, a dramatic recovery was
achieved in the first month with respect to ODI scores and
VAS values (Table 3). In this group, the average VAS value
was 9 (range: 3–10) before application and it decreased
to 5 (range: 2–10) at the end of first month (P < 0.042).
The average ± standard deviation ODI score was 59.2 ±
13.37, reduced to 33.4 ± 10.13 at the end of the first month

(P < 0.001). In the treatment group, patients who showed
positive simple leg raising and femoral stretching tests
were 80% and 77.5%, 40% and 37.5%, and 10% and 15%
before the application, on the third day, and at the end
of the first month, respectively (P < 0.001). A significant
recovery was seen in the motion gap between lumbar and
articular faces when comparing the findings before the
application, on the third day, and in the first month (P <
0.001).
Regarding the patients in the TDP group, VAS values
and ODI scores had a statistically significant minimal
decrease when compared with the baseline values. There
were no statistically significant differences except for
paravertebral muscle spasms and the femoral stretching
test (Table 4).
There was a statistically significant difference between
the two groups before the application and on the third day
after application (Table 5).
Comparing the clinical features of patients on the third
day after the application with all physical examination
findings and scores, a statistically significant difference
between the patients in the ADP group and the patients in
the TDP group was seen (Tables 3–5).
Two patients from the TDP group developed bullous
lesions with serous fluid. They were treated with topical
medications.
In conclusion, we found that application of ADP,
as compared with the control TDP, showed better
improvement in leg pain and sensory deficits.

Figure 2. Flowchart of the study and follow-up of patients.
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Table 2. Clinical features of groups before application. Independent t-test (bootstrap) - Mann–Whitney U
test (Monte Carlo) - Fisher exact test (exact). Average data ± standard deviation; median (range); n (%). ª:
Odds ratio (95% confidence interval for odds ratio); º: reference taken for odds ratio.
Control

Experiment

46 (47.4)

51 (52.6)

ODI

61.8 ± 11.42

60.9 ± 13.15

VAS

8 (3–10)

10 (3–10)

SLR
K-SLR
Flexion

Positive

36 (78.3)

42 (82.4)

Negative

10 (21.7)

9 (17.6)

Positive

32 (69.6)

36 (70.6)

Negative

14 (30.4)

15 (29.4)

P-value
0.724
0.620
1

Normal

18 (39.1)

20 (39.2)

Disabled

28 (60.9)

31 (60.8)

Extension

Normal

19 (41.3)

19 (37.3)

Disabled

27 (58.7)

32 (62.7)

Right L flexion

Normal

19 (41.3)

22 (43.1)

Disabled

27 (58.7)

29 (56.9)

Left L flexion

Normal

19 (41.3)

22 (43.1)

Disabled

27 (58.7)

29 (56.9)

Paravertebral muscle spasm

Yesº

36 (78.3)

48 (94.1)

No

10 (21.7)

3 (5.9)

4.4 (1.1–17.2)ª

Femoral stretching test

Positive

31 (67.4)

38 (74.5)

0.504

Negative

15 (32.6)

13 (25.5)

4. Discussion
The TDP method has been known for a long time and
is used in many medical fields such as nicotine and
postmenopausal hormone replacement, pain treatment,
and antihypertension medications (12). Fentanyl has been
used transdermally in LDHR treatment and recovery of
symptoms of patients has been reported (13,14). However,
the method that we used in this case is a completely
new approach in which the ADP enhances the systemic
circulation. The findings of this study suggest that the
disintegrated herniated disc absorbs the active ingredients
by diffusion and this decreases the intraosmotic pressure
of the herniated nucleus pulposus and results in water loss.
According to the findings of this study, the patients
in the treatment group with sciatica and LDHR showed
significantly important clinical recoveries when compared
with the control group in regards to baseline values. When
we examined the difference before application and at
the third day after application, there was a significantly
higher recovery rate in the ADP group than the control
group regarding the ODI scores, VAS values, and physical
examination findings. For the patients in the ADP group,
ODI scores before the application, on the third day after

1
0.835
1
1
0.035

application, and at the first month after application were
59.2, 44.8, and 33.4, respectively (P < 0.001, Table 3). The
median of VAS values before the application, on the third
day after application, and at the first month after application
were reduced to 9, 7, and 5. These values support the
efficiency of ADP treatment. The mechanism of action
of ADP is supposed to be by reducing the osmolarity of
the disc by the fatty acids that reach the disintegrated disc
and have a lower solute concentration than water. Thus,
the fatty acids were formed with dextrin palmitate, which
reaches the herniated nucleus pulposus and produces a
hypoosmolar medium. The water inside the herniated
nucleus pulposus passes to the hyperoosmolar medium so
that the water content of the disc decreases and the mass
reduces.
In the literature, there are publications indicating
that even massive herniated discs can be reduced and
reabsorbed by long-term follow-ups by conservative
treatment (15 – 21). Significant reduction of symptoms
in conservatively followed patients is seen in the long
term (16–18). Comparing the conservative and surgical
treatments for LDHR patients, there is no superiority of
surgery over long-term conservative treatment (22).
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Table 3. The data before and after application in the experiment group. General linear model-repeated ANOVA (Wilks’ lambda); post
hoc test: LSD; Cochran’s Q test; post hoc test: nonparametric Miller post hoc test. Average data ± standard deviation; median (range);
n (%).
Preoperative = I

3rd day = II

1st month = III

P-value

n = 40

n = 40

n = 40

I–II

I–III

II–III

General

ODI

59.2 ± 13.37

44.8 ± 15.61

33.4 ± 10.13

<0.001

<0.001

<0.001

<0.001

VAS

9 (3–10)

7 (2–10)

5 (2–10)

<0.001

0.042

<0.001

<0.001

Positive

32 (80.0)

16 (40.0)

4 (10.0)

0.001

<0.001

0.016

<0.001

Negative

8 (20.0)

24 (60.0)

36 (90.0)

Positive

32 (80.0)

16 (40.0)

4 (10.0)

<0.001

0.001

0.016

<0.001

Negative

8 (20.0)

24 (60.0)

36 (90.0)

Normal

15 (37.5)

25 (62.5)

33 (82.5)

0.019

<0.001

0.085

<0.001

Disabled

25 (62.5)

15 (37.5)

7 (17.5)

Normal

14 (35.0)

25 (62.5)

32 (80.0)

0.006

<0.001

0.148

<0.001

Disabled

26 (65.0)

15 (37.5)

8 (20.0)

Normal

17 (42.5)

28 (70.0)

32 (80.0)

0.003

<0.001

0.704

<0.001

Disabled

23 (57.5)

12 (30.0)

8 (20.0)

Normal

17 (42.5)

28 (70.0)

32 (80.0)

0.003

<0.001

0.704

<0.001

Disabled

23 (57.5)

12 (30.0)

8 (20.0)

Yes

40 (100.0)

12 (30.0)

8 (20.0)

<0.001

<0.001

1

<0.001

No

0 (0.0)

28 (70.0)

32 (80.0)

Positive

31 (77.5)

15 (37.5)

6 (15.0)

<0.001

<0.001

0.082

<0.001

Negative

9 (22.5)

25 (62.5)

34 (85.0)

SLR
K-SLR
Flexion
Extension
Right lateral flexion
Left lateral flexion
Paravertebral muscle
spasm
Femoral stretching test

The pain of the patient may partially increase after the
8th hour of ADP application until the 24th hour after the
application. We inform the patients about this in order to
ensure their compliance. The reason for this may be that
the hypoosmolar fatty acids diffuse to the herniated disc
and increase the volume of the disc during the first 24
h. We generally see that the symptoms start to decrease
after this period when the diffusion of water starts due to
hypoosmolarity. We also saw that clinical recovery is better
at the end of the first month of ADP application than at
the third day. This finding supports the hypothesis that the
hypoosmolar property of the disc is maintained until the
end of the first month.
Although we did not randomize the groups, we found
that the only statistically
significant difference between the two groups before
the application was the higher rate of paraspinal muscle
spasm in the ADP group. Paraspinal muscle spasms may
occur when the disc hernia is especially anterior to root
irritation (23). In addition, the fact that the disc herniation
is added to other possible physical examination findings
may lead to the patient feeling more pain. However, the
statistically significant difference between the groups
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before ODI administration suggests that the clinical status
of the groups may be similar.
Transforaminal
endoscopic
discectomy
and
microdiscectomy were performed in a study conducted
with the patients’ ODI values, in which the preoperative
ODI value of transforaminal endoscopic discectomy
patients was 43 and the postoperative ODI value was
22, and the preoperative ODI value of the patients who
underwent microdiscectomy was 43 (24). In another study,
31 patients underwent laser-assisted discectomy and the
patients were assessed by preoperative and postoperative
ODI scales. The preoperative ODI value of the patients
was measured as 60 postoperative ODI values of 11 (25).
According to Ahn et al., tubular discectomy used in
lumbar disc herniation was evaluated and preoperatively
the ODI score was 84, while the postoperative ODI score
was 27 (26) In our study, the ODI score fell from 59 before
application to 33 after application. When considering
the possible complications and costs of all these surgical
methods, it is thought that TDP application is effective in
lumbar disc hernia treatment.
Proper patient selection is also an important factor
in the success of clinical treatment of LDHR patients
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Table 4. The data before application and 3rd day after application in control group. Independent t-test
(bootstrap) - Mann–Whitney U test (Monte Carlo) - Fisher exact test (exact). Average data ± standard
deviation; median (range); n (%).
Control
ODI
VAS
SLR
K-SLR
Flexion
Extension
Right L flexion
Left L flexion
Paravertebral muscle spasm
Femoral stretching test

P-value

Preop

3rd day

61.8 ± 11.42

52.2 ± 12.5

<0.001

8 (3–10)

7 (2–10)

<0.001

Positive

29 (74.4)

25 (64.1)

0.219

Negative

10 (25.6)

14 (35.9)

Positive

29 (74.4)

24 (61.5)

Negative

10 (25.6)

15 (38.5)

Normal

17 (43.6)

18 (46.2)

Disabled

22 (56.4)

21 (53.8)

Normal

17 (43.6)

18 (46.2)

Disabled

22 (56.4)

21 (53.8)

Normal

16 (41.0)

18 (46.2)

Disabled

23 (59.0)

21 (53.8)

Normal

17 (43.6)

19 (48.7)

Disabled

22 (56.4)

20 (51.3)

Yes

30 (76.9)

21 (53.8)

No

9 (23.1)

18 (46.2)

Positive

27 (69.2)

20 (51.3)

Negative

12 (30.8)

19 (48.7)

0.063
1
1
0.500
0.500
0.004
0.016

Table 5. The difference between groups before application and the third day after application .General linear model-repeated ANOVA (Wilks’ lambda) - independent t-test (bootstrap) - Mann–Whitney U test (Monte Carlo) - Fisher exact
test (exact). Average data ± standard deviation; median (range); n (%). Odds
ratio (95% confidence interval for odds ratio); º: reference taken for odds ratio.

ODI

VAS

Control

Experiment

P-value

Preoperative

61.8 ± 11.42

60.9 ± 13.15

0.724

3rd day

52.2 ± 12.5

46.0 ± 15.4

difference

8.2 ± 7.7

14.2 ± 12.9

0.010

Preoperative

8 (3–10)

10 (3–10)

<0.001

3rd day

7 (2–10)

7 (2–10)

difference

1 (2–4)

2 (1–8)

when comparing the physical examination results, ODI
scores, and VAS values of ADP-treated patients with
the control group. We prefer the ADP in patients with
clinically diagnosed sciatica with LDHR and radiologically
diagnosed protruded and extruded discs. From the
location point of view, it should be applied to the patients
with central and posterolateral disc hernias. It should not
be applied to patients with stenosis in the vertebral canal,

0.003

mechanic vertebral instability, protrusion, calcification,
lateral access stenosis, advanced motor deficit, or sphincter
defects.
Our study had some limitations. Even though
there was a placebo control group, comparisons with
other control groups such as other lumbar disc hernia
treatments (surgery, epidural steroid injection, etc.) could
increase the power of the study. A longer study period may
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provide more information about the efficacy of the ADP.
Additionally, studies that show the efficacy of the ADP
radiologically could provide more objective data.
In conclusion, ADP application has achieved successful
clinical results for the conservative treatment of LDHR. It

may become a candidate for alternatives of conservative
treatment of LDHR. Clinical trials with more subjects and
a longer period have to be performed in order to support
the effectiveness of the ADP in the treatment of lumbar
disc herniation.
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